Journal of Hepatology Submission Guide: Fit, Structure, and Checklist
A source-checked Journal of Hepatology guide for deciding fit, choosing an article type, and assembling the current EASL/Elsevier submission package.
Readiness scan
Find out if this manuscript is ready to submit.
Run the Free Readiness Scan before you submit. Catch the issues editors reject on first read.
Quick answer: Submit to Journal of Hepatology when the paper makes a cutting-edge basic, translational, or clinical contribution to understanding or managing liver disease. The current official guide gives Original manuscripts a detailed structure and package. Resolve journal and article-type fit before compressing the paper to those requirements.
Evidence basis: The official ScienceDirect journal page, Guide for Authors, and submission route were checked on August 22, 2026. Requirements and journal descriptions are sourced facts; the liver-evidence and routing tests are Manusights judgment. The live guide controls if a word limit, fee, form, or portal field changes.
This source-backed synthesis cannot predict an editorial decision or acceptance outcome. It treats a missing liver-specific consequence as a routing failure mode, not as a forecast of the journal's response.
From our manuscript review practice
Journal of Hepatology and Hepatology are separate journals. The cleanest routing question is whether the paper carries a cutting-edge liver-disease mechanism or management consequence for Journal of Hepatology's EASL readership.
Confirm that Journal of Hepatology owns the paper
The journal covers liver-disease research across metabolic, alcohol-related, viral, autoimmune, cholestatic, genetic, acute, chronic, and malignant disease, plus transplantation and related management questions. Breadth alone is not fit. The manuscript still needs a liver-specific consequence that matters to the journal's readership.
Paper's center | Readiness question |
|---|---|
Basic mechanism | Does the mechanism change understanding of liver disease rather than general cell biology alone? |
Translational study | Is the bridge to patient stratification, diagnosis, prognosis, or treatment supported? |
Clinical study | Are design, endpoints, effect, uncertainty, and practice consequence aligned? |
Imaging or pathology | Does the artifact improve diagnosis or interpretation beyond an illustrative case? |
Do not confuse the title with Hepatology, the separate AASLD journal. They overlap, but society, publisher, submission system, and editorial owner are distinct.
Compare the boundary directly with the Hepatology submission guide and use the best hepatology journals guide when the reader and society audience are still unsettled.
Choose the correct article type
The current guide lists Original manuscripts, fast-track review for eligible time-sensitive major work, solicited Reviews and Seminars, special sections, Editorials, Case reports, and Letters. Do not squeeze a manuscript into the nearest menu label.
For an Original manuscript, the current guide sets a maximum of 6,000 words including abstract, references, tables, and figure legends, no more than eight tables and/or figures, and no more than 100 references. Those are package constraints, not targets. Remove material only when the claim remains reproducible and interpretable.
Build the liver-evidence chain
The strongest preparation order is:
- Disease question: Name the liver disease, stage, population, or biological process.
- Mechanism or decision: State what the paper changes in causal understanding, diagnosis, prognosis, treatment, or management.
- Discriminating evidence: Identify the experiment, cohort, comparator, or analysis that separates the claim from alternatives.
- Boundary: State the model, population, follow-up, endpoint, or uncertainty that limits the conclusion.
For clinical and translational work, keep the patient consequence visible without turning an association into a treatment claim. For basic work, show why the liver context is mechanistically indispensable.
Requirements and Original manuscript order
The current guide specifies this sequence:
Requirement | What to verify |
|---|---|
Title page and cover letter | Concise title, short title, complete authors and affiliations, corresponding author, keywords, counts, and cover letter |
Abstract | Use the journal's current format and keep the conclusion inside the design |
Impact and Implications | Translate the result without overstating practice relevance |
Introduction | Define the liver-specific gap and the decision the study resolves |
Materials/Patients and methods | Make design, ethics approval, statistics, and reporting reproducible |
Results and Discussion | Preserve the evidence sequence and acknowledge limits near the claim |
End matter | Author contributions, conflicts of interest, funding statement, data availability statement, supplementary material, references, tables, legends, and figures remain consistent |
The title page instructions currently cap the title at 130 characters, request a short title of no more than 50 characters, and ask for three to twelve keywords. Recheck the live guide at upload.
After submission: an honest stage map
Journal of Hepatology does not promise a case-specific schedule or guarantee that every submission reaches review. Use the four-stage map to interpret correspondence without inventing sentiment:
- Package screening: The office checks files, article type, declarations, and technical completeness.
- Editorial assessment: Editors evaluate liver-disease significance, scope, and whether the inference level fits the evidence.
- Peer review: If selected, reviewers examine the design, reporting, analysis, and clinical or mechanistic consequence.
- Editorial synthesis: The editor reconciles the reports and communicates a decision or bounded revision request.
Compare the nearest owners before formatting
Decision | Journal of Hepatology | Hepatology | JHEP Reports |
|---|---|---|---|
Central protagonist | Liver-disease mechanism or management consequence | High-priority liver science for the AASLD audience | Open-access hepatology research with a clear specialist contribution |
Evidence emphasis | Inference ladder from result to liver consequence | Field significance and mechanistic or clinical importance | Complete, transparent evidence and specialist usefulness |
Hold when | The liver context is incidental | The breadth case exists only in promotional language | The paper needs a different article shape or audience |
What our source comparison adds
Manusights internal analysis identifies a distinctive coupling of liver-disease significance with a tightly specified review artifact across the official aims, article-type rules, title-page requirements, and screening language. The package asks authors to state “Impact and Implications” while the scope spans both mechanism and management. Those two surfaces should not tell different stories.
Source limitations: The publisher materials specify the submission package but cannot establish how an editor will weigh a particular study. Beyond official guidance, the inference ladder below is a preparation tool for keeping claims consistent; it is not an EASL acceptance rule.
We use an implication ladder to test them. Start with the direct result, then move one rung at a time through biological interpretation, liver-disease interpretation, patient relevance, and management consequence. Stop at the highest rung directly supported by the design. A cell or animal study may clear a strong disease-mechanism rung without clearing a patient-management rung. A clinical association may clear prognostic relevance without clearing treatment choice.
Highest supported rung | Appropriate language |
|---|---|
Direct result | What was measured or estimated, with uncertainty |
Mechanism | What causal or discriminating evidence establishes |
Disease meaning | What changes in understanding a liver condition |
Patient consequence | What the represented population can reasonably support |
Management consequence | What a trial, decision design, or sufficiently strong evidence can change |
This ladder is Manusights judgment, not an EASL rule. Its purpose is to keep the title, abstract, Impact and Implications section, figures, and discussion at the same inference level. If the manuscript belongs in another liver or GI venue, compare the current owners through the journal directory rather than using a metric as a proxy.
Concrete package facts
The current guide sets 6,000 words for Original manuscripts including the abstract, references, tables, and figure legends; eight combined tables and/or figures; and 100 references. It asks for a title of no more than 130 characters, a short title of no more than 50 characters, and three to twelve keywords. It routes submissions through Editorial Manager at editorialmanager.com/jhepat. These are current administrative facts, not quality thresholds or timing promises.
Complete reporting, ethics, and data work
Choose reporting guidance by design rather than by journal prestige. Trials, observational studies, diagnostic accuracy work, systematic reviews, animal work, and other designs need the appropriate checklist and registration or protocol context.
The current guide requires relevant declarations and describes screening before peer review. Treat the package as one system:
- ethics approval and informed consent match the methods and portal
- interests and funding roles are explicit
- author names and order match every file
- statistics support the endpoint and multiplicity structure
- data availability identifies access, repository, or justified restriction
- figures preserve image integrity and do not duplicate the tables
Common rejection triggers and early preparation failures
General biology with a liver label: The mechanism is real, but the liver context is not scientifically necessary.
Translational leap: A model or retrospective association is framed as a treatment or guideline conclusion.
Article-type mismatch: A regular study is pushed into fast track or a case report despite not meeting the distinct purpose.
Compression damage: Essential methods, uncertainty, or limitations disappear to meet the package size.
The implication jump: The required Impact and Implications text moves from a model or association directly to clinical management without the intermediate evidence.
Readiness check
Run the scan against the requirements while they're in front of you.
See score, top issues, and journal-fit signals before you submit.
Final checklist
- [ ] Journal of Hepatology,not Hepatology,owns the reader job.
- [ ] The current article type and limits are verified.
- [ ] The liver-specific mechanism or decision consequence is answer-first.
- [ ] Title page, abstract, Impact and Implications, and main text agree.
- [ ] Reporting, ethics, statistics, data, and declarations are complete.
- [ ] Figures, tables, legends, and references fit the current package.
- [ ] The live submission route and any fee have been rechecked.
Submit If
- Liver disease is the indispensable scientific or clinical context.
- The design can support the mechanism or management consequence being claimed.
- The article type and manuscript structure match the live guide.
- Reporting, ethics, data, images, and declarations form one auditable package.
Think Twice If
- The abstract's main contribution belongs more naturally in general GI, oncology, immunology, metabolism, or basic biology.
- The first figure implies a clinical consequence beyond the sample, endpoint, follow-up, or study design.
- The manuscript must hide methods or limitations to fit the word or display-item cap.
- The target has been selected by metric rather than reader and decision fit.
Frequently asked questions
The official Guide for Authors routes manuscripts through the journal's Editorial Manager submission system. Follow the live link in the guide rather than an old bookmark.
The EASL flagship publishes basic, translational, and clinical research on liver disease, including mechanisms and management strategies across major hepatology areas.
The current official guide states that Original manuscripts should not exceed 6,000 words including the abstract, references, tables, and figure legends, with up to eight tables and/or figures and up to 100 references.
No. Journal of Hepatology is the EASL flagship published by Elsevier. Hepatology is the AASLD journal and has its own submission owner and requirements.
Sources
- Journal of Hepatology journal page and aims and scope
- Journal of Hepatology Guide for Authors
- Journal of Hepatology submission system
- Use the publisher guide for administrative truth. Use the ownership and evidence tests to decide whether the paper earns this specific liver audience.
Before you upload
Choose the next useful decision step first.
Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.
Use the scan once the manuscript and target journal are concrete enough to evaluate.
Anthropic Privacy Partner. Your manuscript is never used to train any model.